Jubilant Pharmova Limited (JUBLPHARMA.NS)
INR 1085.05
(-0.42%)
INR 1085.05
(-0.42%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 19.64 Billion INR | -54.75% |
| 2022 | 43.41 Billion INR | 1.62% |
| 2021 | 42.72 Billion INR | 1.47% |
| 2020 | 42.1 Billion INR | -23.75% |
| 2019 | 55.22 Billion INR | 6.69% |
| 2018 | 51.75 Billion INR | 20.9% |
| 2017 | 42.81 Billion INR | 21.87% |
| 2016 | 35.13 Billion INR | 5.51% |
| 2015 | 33.29 Billion INR | 16.51% |
| 2014 | 28.57 Billion INR | -5.83% |
| 2013 | 30.34 Billion INR | -1.89% |
| 2012 | 30.92 Billion INR | 49.32% |
| 2011 | 20.71 Billion INR | 0.36% |
| 2010 | 20.63 Billion INR | 180.63% |
| 2009 | 7.35 Billion INR | -60.85% |
| 2008 | 18.78 Billion INR | 42.34% |
| 2007 | 13.19 Billion INR | 56.96% |
| 2006 | 8.4 Billion INR | 287.37% |
| 2005 | 2.17 Billion INR | -57.36% |
| 2004 | 5.09 Billion INR | 20.85% |
| 2003 | 4.21 Billion INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 5.26 Billion INR | -8.48% |
| 2024 Q2 | 11.87 Billion INR | 2.93% |
| 2023 Q1 | 10.46 Billion INR | -7.49% |
| 2023 Q3 | 11.29 Billion INR | 1.79% |
| 2023 Q2 | 11.09 Billion INR | 6.02% |
| 2023 Q4 | 5.75 Billion INR | -49.07% |
| 2023 FY | 19.64 Billion INR | -54.75% |
| 2022 Q2 | 11.01 Billion INR | 4.57% |
| 2022 FY | 43.41 Billion INR | 1.62% |
| 2022 Q4 | 11.31 Billion INR | 7.2% |
| 2022 Q3 | 10.55 Billion INR | -4.22% |
| 2022 Q1 | 10.53 Billion INR | 31.57% |
| 2021 FY | 42.72 Billion INR | 1.47% |
| 2021 Q4 | 8 Billion INR | -21.82% |
| 2021 Q1 | 12.52 Billion INR | 32.55% |
| 2021 Q3 | 10.24 Billion INR | -14.25% |
| 2021 Q2 | 11.94 Billion INR | -4.66% |
| 2020 Q2 | 14.75 Billion INR | 20.42% |
| 2020 FY | 42.1 Billion INR | -23.75% |
| 2020 Q4 | 9.45 Billion INR | -26.46% |
| 2020 Q1 | 12.25 Billion INR | 6.16% |
| 2020 Q3 | 12.85 Billion INR | -12.91% |
| 2019 Q1 | 13.97 Billion INR | 29.4% |
| 2019 FY | 55.22 Billion INR | 6.69% |
| 2019 Q2 | 14.63 Billion INR | 4.7% |
| 2019 Q3 | 15.06 Billion INR | 2.96% |
| 2019 Q4 | 11.54 Billion INR | -23.38% |
| 2018 Q1 | 12.5 Billion INR | -6.22% |
| 2018 Q4 | 10.8 Billion INR | -26.89% |
| 2018 FY | 51.75 Billion INR | 20.9% |
| 2018 Q3 | 14.77 Billion INR | 7.95% |
| 2018 Q2 | 13.68 Billion INR | 9.47% |
| 2017 Q1 | 9.72 Billion INR | -3.56% |
| 2017 FY | 42.81 Billion INR | 21.87% |
| 2017 Q4 | 13.32 Billion INR | 4.06% |
| 2017 Q3 | 12.8 Billion INR | 23.86% |
| 2017 Q2 | 10.34 Billion INR | 6.32% |
| 2016 Q3 | 9.49 Billion INR | 4.96% |
| 2016 Q4 | 10.08 Billion INR | 6.26% |
| 2016 Q2 | 9.04 Billion INR | -3.46% |
| 2016 FY | 35.13 Billion INR | 5.51% |
| 2016 Q1 | 9.36 Billion INR | 2.24% |
| 2015 FY | 33.29 Billion INR | 16.51% |
| 2015 Q1 | 8.92 Billion INR | 61.46% |
| 2015 Q2 | 9.14 Billion INR | 2.45% |
| 2015 Q3 | 8.55 Billion INR | -6.46% |
| 2015 Q4 | 9.16 Billion INR | 7.12% |
| 2014 Q3 | 8.07 Billion INR | 6.86% |
| 2014 Q4 | 5.52 Billion INR | -31.56% |
| 2014 Q2 | 7.55 Billion INR | 1.96% |
| 2014 FY | 28.57 Billion INR | -5.83% |
| 2014 Q1 | 7.41 Billion INR | 21.17% |
| 2013 FY | 30.34 Billion INR | -1.89% |
| 2013 Q4 | 6.11 Billion INR | -26.5% |
| 2013 Q3 | 8.32 Billion INR | -2.54% |
| 2013 Q2 | 8.54 Billion INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2012 Q3 | 7.67 Billion INR | 1.8% |
| 2012 FY | 30.92 Billion INR | 49.32% |
| 2012 Q4 | 7.99 Billion INR | 4.28% |
| 2012 Q2 | 7.53 Billion INR | 0.0% |
| 2012 Q1 | - INR | -100.0% |
| 2011 FY | 20.71 Billion INR | 0.36% |
| 2011 Q3 | 6.91 Billion INR | 0.0% |
| 2011 Q4 | 1.41 Billion INR | -79.57% |
| 2010 FY | 20.63 Billion INR | 180.63% |
| 2009 FY | 7.35 Billion INR | -60.85% |
| 2008 FY | 18.78 Billion INR | 42.34% |
| 2007 FY | 13.19 Billion INR | 56.96% |
| 2006 FY | 8.4 Billion INR | 287.37% |
| 2005 FY | 2.17 Billion INR | -57.36% |
| 2004 FY | 5.09 Billion INR | 20.85% |
| 2003 FY | 4.21 Billion INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Sigachi Industries Limited | 2 Billion INR | -881.03% |
| Ind-Swift Limited | 2.17 Billion INR | -804.153% |
| Bajaj HealthCare Limited | 1.47 Billion INR | -1234.619% |
| Sakar Healthcare Limited | 699.58 Million INR | -2707.807% |
| Aurobindo Pharma Limited | 109.54 Billion INR | 82.068% |
| Innova Captab Limited | 3.46 Billion INR | -466.989% |
| Divi's Laboratories Limited | 32.44 Billion INR | 39.448% |
| AstraZeneca Pharma India Limited | 6.22 Billion INR | -215.667% |
| Morepen Laboratories Limited | 6.16 Billion INR | -218.814% |
| Mankind Pharma Limited | 42.19 Billion INR | 53.449% |
| Sequent Scientific Limited | 2.97 Billion INR | -559.442% |
| Wanbury Limited | 1.73 Billion INR | -1035.012% |
| Laurus Labs Limited | 15.44 Billion INR | -27.15% |
| Nectar Lifesciences Limited | 4.82 Billion INR | -307.253% |
| Glenmark Life Sciences Limited | 12.43 Billion INR | -57.991% |
| Alembic Limited | 1 Billion INR | -1864.09% |
| Hikal Limited | 5.95 Billion INR | -229.691% |
| Alembic Pharmaceuticals Limited | 26.78 Billion INR | 26.652% |
| Neuland Laboratories Limited | 8.24 Billion INR | -138.159% |
| J. B. Chemicals & Pharmaceuticals Limited | 15.25 Billion INR | -28.731% |
| Glenmark Pharmaceuticals Limited | 69.34 Billion INR | 71.672% |
| IOL Chemicals and Pharmaceuticals Limited | 4.71 Billion INR | -316.245% |
| Themis Medicare Limited | 2.42 Billion INR | -711.692% |
| RPG Life Sciences Limited | 2.48 Billion INR | -691.099% |
| Zydus Lifesciences Limited | 125.21 Billion INR | 84.312% |
| Lupin Limited | 125.09 Billion INR | 84.298% |
| Amrutanjan Health Care Limited | 2.09 Billion INR | -838.045% |
| Wockhardt Limited | 7.72 Billion INR | -154.443% |
| Vaishali Pharma Limited | 90.32 Million INR | -21647.506% |
| Aarti Pharmalabs Limited | 5.83 Billion INR | -236.852% |
| Jagsonpal Pharmaceuticals Limited | 652.59 Million INR | -2910.006% |
| FDC Limited | 6.58 Billion INR | -198.244% |
| Dr. Reddy's Laboratories Limited | 163.6 Billion INR | 87.994% |
| Kilitch Drugs (India) Limited | 620.47 Million INR | -3065.79% |
| Eris Lifesciences Limited | 10.42 Billion INR | -88.39% |
| Venus Remedies Limited | 2.18 Billion INR | -799.988% |
| ZIM Laboratories Limited | 1.26 Billion INR | -1449.361% |
| Bliss GVS Pharma Limited | 3.69 Billion INR | -431.548% |
| Par Drugs and Chemicals Limited | 529.13 Million INR | -3612.278% |
| Caplin Point Laboratories Limited | 9.2 Billion INR | -113.36% |
| Shilpa Medicare Limited | 3.56 Billion INR | -451.476% |
| Albert David Limited | 1.4 Billion INR | -1295.013% |
| Ajanta Pharma Limited | 21.06 Billion INR | 6.746% |
| Hester Biosciences Limited | 1.27 Billion INR | -1442.26% |
| Suven Pharmaceuticals Limited | 4.12 Billion INR | -376.393% |
| Solara Active Pharma Sciences Limited | -1.65 Billion INR | 1286.243% |
| Gufic Biosciences Limited | 4.07 Billion INR | -382.187% |
| Windlas Biotech Limited | 1.33 Billion INR | -1367.209% |
| Procter & Gamble Health Limited | 5.78 Billion INR | -239.762% |
| Aarey Drugs & Pharmaceuticals Limited | 113.02 Million INR | -17278.726% |
| Mangalam Drugs & Organics Limited | 691.19 Million INR | -2741.898% |
| Granules India Limited | 16.79 Billion INR | -16.928% |
| Aarti Drugs Limited | 8.31 Billion INR | -136.202% |
| Bal Pharma Limited | 770.19 Million INR | -2450.393% |
| Alkem Laboratories Limited | 52.29 Billion INR | 62.439% |
| Sun Pharmaceutical Industries Limited | 258.48 Billion INR | 92.401% |
| Lincoln Pharmaceuticals Limited | 1.88 Billion INR | -941.038% |
| Medicamen Biotech Limited | 495.49 Million INR | -3864.319% |
| Unichem Laboratories Limited | 4.86 Billion INR | -303.767% |
| Bafna Pharmaceuticals Limited | 452.15 Million INR | -4244.326% |
| Biofil Chemicals and Pharmaceuticals Limited | 12.54 Million INR | -156480.311% |
| Valiant Laboratories Limited | 138.02 Million INR | -14131.067% |
| Orchid Pharma Limited | 2.32 Billion INR | -746.57% |
| Medico Remedies Limited | 262.14 Million INR | -7393.21% |
| Ind-Swift Laboratories Limited | 4.13 Billion INR | -375.247% |
| Ipca Laboratories Limited | 48.58 Billion INR | 59.569% |
| Brooks Laboratories Limited | 65.62 Million INR | -29834.471% |
| Syncom Formulations (India) Limited | 559.5 Million INR | -3410.794% |
| Piramal Enterprises Limited | 8.04 Billion INR | -144.216% |
| Torrent Pharmaceuticals Limited | 46.75 Billion INR | 57.989% |
| NATCO Pharma Limited | 25.73 Billion INR | 23.675% |
| Suven Life Sciences Limited | -200.79 Million INR | 9882.517% |
| Krebs Biochemicals & Industries Limited | -108.74 Million INR | 18163.027% |
| Strides Pharma Science Limited | 14.38 Billion INR | -36.522% |
| Indoco Remedies Limited | 8.04 Billion INR | -144.225% |
| Alpa Laboratories Limited | 188.89 Million INR | -10298.899% |
| Lasa Supergenerics Limited | 121.02 Million INR | -16129.86% |
| Sun Pharma Advanced Research Company Limited | 391.06 Million INR | -4922.937% |